Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-14

Clinical Trial Update: A Study to Evaluate the Performance and Safety of CBL-102 Versus Vismed® Multi Eye Drops in the Management of Dry Eye [NA]

View source ↗

Summary

A completed clinical trial comparing CBL-102 to Vismed Multi Eye Drops in the management of Dry Eye, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CBL-102
  • Vismed Multi Eye Drops (artificial tears)

Snippet

Sponsor: Laboratoire Chauvin | Conditions: Dry Eye | NA | Status: COMPLETED | Results posted: 2025-05-14